6 completed, 1 terminated. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Terminated 1 |
Follow Coronary Artery Bypass: new trials by email Literature Review of Coronary Artery Bypass trials Research Report on Coronary Artery Bypass
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF L-alanyl-L-glutamine dipeptide, Placebo - Coronary Artery Bypass, Cardiopulmonary Bypass | Phase 3 | Completed | National Cardiovascular Center Harapan Kita Hospital Indonesia | 60 | 2021-01-01 | 2023-11-13 |
| Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis Prasugrel, Placebo - Coronary Artery Bypass | Phase 3 | Completed | VA Office of Research and Development | 84 | 2013-02-01 | 2019-10-30 |
| A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon Xenon, Sevoflurane - Xenon, Sevoflurane | Phase 3 | Completed | RWTH Aachen University | 30 | 2011-05-01 | 2011-10-06 |
| The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) Acadesine, Normal Saline - Coronary Artery Bypass, Myocardial Infarction | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 3080 | 2009-04-01 | 2015-10-29 |
| Glutamate for Metabolic Intervention in Coronary Surgery Intravenous infusion of saline, Intravenous glutamate infusion - Coronary Artery Bypass, Myocardial Ischemia | Phase 3 | Completed | University Hospital, Linkoeping | 865 | 2005-10-01 | 2024-05-22 |
| The SOS (Stenting Of Saphenous Vein Grafts) Trial Taxus polymer-based paclitaxel-eluting stent, Express 2 bare metal stent - Coronary Artery Bypass, Arteriosclerosis | Phase 3 | Completed | North Texas Veterans Healthcare System | 80 | 2005-05-01 | 2012-04-26 |
| Short-Stay Intensive Care for Coronary Artery Bypass Patients Control group (usual care), Short-Stay Intensive Care treatment (SSIC) - Coronary Artery Bypass | Phase 3 | Completed | Maastricht University Medical Center | 597 | 2001-01-01 | 2017-02-24 |
Coronary Artery Disease (2) · Myocardial Infarction (2) · Angina, Unstable (1) · Arteriosclerosis (1) · Coronary Disease (1) · Coronary Restenosis (1) · Myocardial Ischemia (1) · Respiratory Aspiration (1) · Stroke (1) · Thrombosis (1) · Ventricular Dysfunction, Left (1)
Cardiovascular Diseases (6) · Vascular Diseases (6) · Heart Diseases (5) · Myocardial Ischemia (4) · Arterial Occlusive Diseases (3) · Coronary Disease (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Arteriosclerosis (2) · Infarction (2) · Ischemia (2) · Necrosis (2) · Angina Pectoris (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Saline Solution (2) · Control Groups (1) · Prasugrel Hydrochloride (1) · Sevoflurane (1) · Xenon (1) · acadesine (1) · alanylglutamine (1)
Maastricht University Medical Center (1) · Merck Sharp & Dohme LLC (1) · National Cardiovascular Center Harapan Kita Hospital Indonesia (1) · North Texas Veterans Healthcare System (1) · RWTH Aachen University (1) · University Hospital, Linkoeping (1) · VA Office of Research and Development (1)
United States (2) · Germany (1) · Greece (1) · Indonesia (1) · Netherlands (1) · Sweden (1)
Emmanouil S Brilakis, MD, PhD (1) · Ghislaine van Mastrigt, Msc (1) · I Made Adi Parmana (1) · Mark Coburn, PD Dr. med. (1) · Rolf Svedjeholm, MD PhD (1) · Shuaib M. Abdullah, MD (1)
PMID 16374158, PMID 19281920, PMID 19778774, PMID 19853332, PMID 20665875, PMID 21200334, PMID 21349456, PMID 21646644, PMID 22782417, PMID 22989031, PMID 23578862, PMID 24727704, PMID 25218533, PMID 26467531, PMID 27484576, PMID 32393387, PMID 34253255, PMID 38252440